Alex Wu - 18 Mar 2026 Form 3 Insider Report for CASI Pharmaceuticals, Inc. (CASIF)

Reporting relationship: Director
Issuer ticker: CASIF
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 25 Mar 2026, 07:36:36 UTC
Source filing: View source filing
Reporting owner signature: /s/ Alex Wu

Key filing fact

Alex Wu filed Form 3 for CASI Pharmaceuticals, Inc. (CASIF) on 25 Mar 2026.

Key facts

This page summarizes Alex Wu's Form 3 filing for CASI Pharmaceuticals, Inc. (CASIF).
0 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 25 Mar 2026, 07:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001570852 Primary reporting owner

Wu Alex

Relationship: Director
Address: 601 GATEWAY BLVD, SUITE 1250, SOUTH SAN FRANCISCO
Signature: /s/ Alex Wu
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CASIF holding

Ordinary Share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 34,168
Date: 18 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CASIF holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Share
Underlying amount: 11,045
Exercise price: $1.93
Footnotes: F1

CASIF holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Share
Underlying amount: 38,838
Exercise price: $1.93
Footnotes: F1

CASIF holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Share
Underlying amount: 11,753
Exercise price: $1.93
Footnotes: F1

CASIF holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Share
Underlying amount: 20,000
Exercise price: $3.59
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options are fully vested and exercisable as of the date of this form.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .